---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-076186"
form_type: "8-K"
ticker: "DMRA"
cik: "0001800315"
company_name: "Damora Therapeutics, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:56:15.814829+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Galecto shareholders approve reverse stock split and elect Anne Prener to board

## Summary
- Director Anne Prener elected with 10,651,770 for, 711,618 withheld; 5,840,793 broker non-votes.
- Reverse stock split approved (ratio 1:4 to 1:25, board to decide within one year): 15,283,182 for, 1,830,713 against.
- Ratification of EY as auditor for FY2024 passed with 16,927,703 for, 197,148 against.
- Total shares entitled to vote: 27,112,697; 17,204,181 present or represented.

## SEC filing metadata
- accession: 0000950170-24-076186
- form_type: 8-K
- ticker: DMRA
- cik: 0001800315
- company_name: Damora Therapeutics, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/0000950170-24-076186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/glto-20240620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-076186
- JSON: https://secwatch.observer/filing/0000950170-24-076186.json
- Plain text: https://secwatch.observer/filing/0000950170-24-076186.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.